Plain-English translation of NCT06548542 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Crohn's Disease research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing four new targeted medications—, , , and —to see how well they work for adults with moderate to severe Crohn's disease. Some participants will receive one medication alone, while others will receive two medications together. The study will measure how much these treatments reduce inflammation and improve symptoms.
Current Crohn's disease treatments don't work the same way for everyone, and some stop working over time. This trial is designed to find new, more effective options for patients whose symptoms aren't controlled by existing therapies.
You likely qualify if…
You likely don't qualify if…
If you join, you'll be randomly assigned to receive one of the new treatments—either as an injection under the skin or through an IV infusion—on a schedule determined by your group. You'll attend regular clinic or hospital visits for blood tests, endoscopies, physical exams, and to report any side effects, and you'll keep a daily diary of your symptoms. The study may require more frequent visits than your regular Crohn's care, but it aims to help doctors find better ways to control your disease.
AI-generated summary from trial data · Jul 3, 2026 · Not medical advice
United States